Capital Fund Management S.A. decreased its stake in shares of IMS Health Holdings Inc. (NYSE:IMS) by 84.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,996 shares of the company’s stock after selling 56,218 shares during the period. Capital Fund Management S.A.’s holdings in IMS Health Holdings were worth $253,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently modified their holdings of the stock. Artemis Investment Management LLP purchased a new position in shares of IMS Health Holdings during the second quarter valued at approximately $17,952,000. Pitcairn Co. boosted its position in shares of IMS Health Holdings by 7.5% in the second quarter. Pitcairn Co. now owns 8,937 shares of the company’s stock valued at $226,000 after buying an additional 625 shares in the last quarter. Shell Asset Management Co. boosted its position in shares of IMS Health Holdings by 520.7% in the second quarter. Shell Asset Management Co. now owns 47,919 shares of the company’s stock valued at $1,215,000 after buying an additional 40,199 shares in the last quarter. CIBC World Markets Inc. purchased a new position in shares of IMS Health Holdings during the second quarter valued at approximately $456,000. Finally, LS Investment Advisors LLC boosted its position in shares of IMS Health Holdings by 14.0% in the second quarter. LS Investment Advisors LLC now owns 4,982 shares of the company’s stock valued at $126,000 after buying an additional 611 shares in the last quarter. 90.25% of the stock is owned by institutional investors.
Shares of IMS Health Holdings Inc. (NYSE:IMS) remained flat at $31.34 during midday trading on Friday. IMS Health Holdings Inc. has a one year low of $22.36 and a one year high of $31.59. The firm has a 50-day moving average price of $30.37 and a 200-day moving average price of $27.68.
IMS Health Holdings (NYSE:IMS) last released its earnings results on Wednesday, July 27th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.03. The company earned $802 million during the quarter, compared to analyst estimates of $796.93 million. IMS Health Holdings had a net margin of 4.45% and a return on equity of 30.61%. The firm’s quarterly revenue was up 112.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.37 EPS. Equities research analysts predict that IMS Health Holdings Inc. will post $1.62 earnings per share for the current year.
Several equities research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of IMS Health Holdings from a “hold” rating to a “buy” rating and set a $34.00 target price for the company in a research report on Wednesday, September 28th. TheStreet lowered shares of IMS Health Holdings from a “buy” rating to a “hold” rating in a research report on Monday, August 29th. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $31.00.
About IMS Health Holdings
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.